For an investor focusing on the business, it might only be long enough to hear one quarterly update from management. To keep from getting whiplash, investors in Twist Bioscience (NASDAQ: TWST) and Pacific Biosciences of California (NASDAQ: PACB) will need to be focused on the long-term opportunity for synthetic DNA and long-read genome sequencing, respectively. Each company has a unique position in the life science industry, but short-term volatility could shake the confidence of anyone worried about the stock price over the next year or two.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting